Releases
MRNS
--
0.00%
--
  • All
  • Financials
  • Insiders
More
Webull provides the latest Marinus Pharms (MRNS) stock and general news. This information may help you make smarter investment decisions.
About MRNS
Marinus Pharmaceuticals Inc is a United States-based biopharmaceutical company. The Company offers development and commercialization of medical drugs for the treatment of serious neurological and psychiatric disorders such as epilepsy, post-traumatic stress, and fragile-x syndrome. Its clinical-stage product candidate, ganaxolone, is a modulator being developed in various dose forms, including intravenous, oral capsule and oral liquid, intended to provide more treatment options to adult and pediatric patient populations in both acute and chronic care settings.